EVELO BIOSCIENCES INC (EVLO) Total Assets by Year
EVELO BIOSCIENCES INC closed fiscal year 2022 with $64.4M in total assets, $69.4M in total liabilities and -$5.0M in shareholder equity. This represents a decrease of 26.7% from the prior fiscal year. The table below carries 7 fiscal years, from 2016 to 2022, and the quarters EVELO BIOSCIENCES INC has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
EVLO Balance Sheet by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
| Metric | FY2210-K | FY2110-K | FY2010-K | FY1910-K | FY1810-K | FY1710-K | FY1610-K |
|---|---|---|---|---|---|---|---|
| Total Assets | $64.4M-26.7% | $87.9M-3.1% | $90.6M-0.3% | $90.9M-43.1% | $159.9M+265.1% | $43.8M | N/A |
| Total Liabilities | $69.4M-12.3% | $79.2M+31.7% | $60.2M+95.8% | $30.7M+34.1% | $22.9M-76.7% | $98.5M | N/A |
| Total Equity | -$5.0M-157.6% | $8.7M-71.6% | $30.5M-49.4% | $60.2M-56.0% | $136.9M+350.3% | -$54.7M-93.1% | -$28.3M |
EVLO Balance Sheet by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
| Metric | Q3'2310-Q | Q2'2310-Q | Q1'2310-Q | Q4'2210-Q | Q3'2210-Q | Q2'2210-Q | Q1'2210-Q | Q4'2110-K | Q3'2110-Q | Q2'2110-Q | Q1'2110-Q | Q4'2010-K |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $20.6M-76.1% | $20.8M-81.4% | $42.0M-28.7% | $64.4M-26.7% | $86.3M-25.9% | $111.9M-22.9% | $58.8M-61.6% | $87.9M-3.1% | $116.5M+11.1% | $145.1M+27.3% | $153.0M+84.1% | $90.6M-0.3% |
| Total Liabilities | $47.3M-38.5% | $66.9M-12.2% | $69.4M-8.3% | $69.4M-12.3% | $77.0M-7.7% | $76.3M-8.1% | $75.6M+16.0% | $79.2M+31.7% | $83.4M+53.3% | $83.0M+85.6% | $65.2M+48.9% | $60.2M+95.8% |
| Total Equity | -$26.7M-386.1% | -$46.1M-229.4% | -$27.4M-63.0% | -$5.0M-157.6% | $9.3M-71.8% | $35.6M-42.6% | -$16.8M-119.1% | $8.7M-71.6% | $33.1M-34.4% | $62.1M-10.3% | $87.8M+123.3% | $30.5M-49.4% |
What total assets means
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders.
More EVELO BIOSCIENCES INC financials
Frequently Asked Questions
What was EVELO BIOSCIENCES INC's total assets in fiscal year 2022?
EVELO BIOSCIENCES INC closed fiscal year 2022 with $64.4M in total assets, $69.4M in total liabilities and -$5.0M in shareholder equity.
How fast is EVELO BIOSCIENCES INC's total assets growing?
EVELO BIOSCIENCES INC (EVLO) total assets fell by 26.7% year over year, from $87.9M to $64.4M in fiscal year 2022.
What was EVELO BIOSCIENCES INC's total assets in the most recent quarter?
EVELO BIOSCIENCES INC (EVLO) reported $20.6M in total assets in Q3 2023. This represents a decrease of 76.1% from the same quarter a year earlier.
What does total assets mean on a financial statement?
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders. This page lists what EVELO BIOSCIENCES INC (EVLO) reported on that line in every period on record.